Found: 10
Select item for more details and to access through your institution.
MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032832
- By:
- Publication type:
- Article
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
- Published in:
- Prostate, 2015, v. 75, n. 13, p. 1341, doi. 10.1002/pros.23015
- By:
- Publication type:
- Article
Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
- Published in:
- Prostate, 2014, v. 74, n. 11, p. 1086, doi. 10.1002/pros.22819
- By:
- Publication type:
- Article
Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells.
- Published in:
- Prostate, 2014, v. 74, n. 2, p. 201, doi. 10.1002/pros.22741
- By:
- Publication type:
- Article
RhoGDIα downregulates androgen receptor signaling in prostate cancer cells.
- Published in:
- Prostate, 2013, v. 73, n. 15, p. 1614, doi. 10.1002/pros.22615
- By:
- Publication type:
- Article
Functional p53 determines docetaxel sensitivity in prostate cancer cells.
- Published in:
- Prostate, 2013, v. 73, n. 4, p. 418, doi. 10.1002/pros.22583
- By:
- Publication type:
- Article
RhoGDIα suppresses growth and survival of prostate cancer cells.
- Published in:
- Prostate, 2012, v. 72, n. 4, p. 392, doi. 10.1002/pros.21441
- By:
- Publication type:
- Article
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.
- Published in:
- Prostate, 2012, v. 72, n. 1, p. 82, doi. 10.1002/pros.21409
- By:
- Publication type:
- Article
Adsorption of Tetracycline with Reduced Graphene Oxide Decorated with MnFe<sub>2</sub>O<sub>4</sub> Nanoparticles.
- Published in:
- Nanoscale Research Letters, 2018, v. 13, n. 1, p. 1, doi. 10.1186/s11671-018-2814-9
- By:
- Publication type:
- Article
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15396-5
- By:
- Publication type:
- Article